Similar Items: Global Patterns, Temporal Trends, and Potential Non-Infectious Risk Factors for Burkitt Lymphoma from 1990 to 2021
- Comprehensive Evaluation of Drug-Related Problems and Pharmacotherapy Patterns in Non-Hodgkin’s Lymphoma Patients in Yemen
- Clinical and biological aspects of aggressive B-cell non-Hodgkin lymphoma in adolescents and young adults
- Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
- Prognostic Impact of ALK on Anaplastic Large Cell Lymphoma of CNS
- Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis—a Rare and Dangerous Disease
- Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adults